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Covalent bond formation has become a safe and effective strategy applied not only by nature 
but also by the pharmaceutical industry to improve disease pharmacology. In the history of modern 
medicine, covalent drugs have been broadly used in many therapies for a wide range of human 
diseases [1]. Many modern drugs hold electrophilic moieties acting as “warheads” that capture the 
active sites by reacting with endogenous nucleophilic functionalities (e.g., thiols and amines). 
In the domain of natural products and related compounds, the aziridine moiety is an illustrative 
class of warhead, which may react with nucleophilic partners of target enzymes and share a similar 
reaction mechanism to allow the formation of covalent bonds. Aziridines are also important synthetic 
targets themselves, since they appear in naturally occurring compounds with applications in 
medicinal chemistry [2]. Aziridines, as powerful alkylating agents, may act as covalent drugs, having 
an intrinsic in vivo potency by means of their capability to act as DNA cross-linking agents via 
nucleophilic ring opening of the three-membered heterocyclic compounds [3]. 
This work describes an efficient diastereoselective synthetic methodology for the preparation of 
phosphorus substituted cyanoaziridines though the nucleophilic addition of TMSCN, as a cyanide 
source, to the C–N double bond of 2H-azirine derivatives. The aziridine ring, in these new 
cyanoaziridines, can be activated by simple N-acylation or N-tosylation. In addition, the cytotoxic 
effect on cell lines derived from human lung adenocarcinoma (A549) and human embryonic kidney 
(HEK293) was screened. N–H and N-Substituted cyanoaziridines showed excellent activity against 
the A549 cell line in vitro. Moreover, selectivity towards cancer cell (A549) over (HEK293) and 
nonmalignant cells (MCR-5) has been observed. 
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